NL101 synergizes with the BCL-2 inhibitor venetoclax through PI3K-dependent suppression of c-Myc in acute myeloid leukaemia.
Saved in:
| Title: | NL101 synergizes with the BCL-2 inhibitor venetoclax through PI3K-dependent suppression of c-Myc in acute myeloid leukaemia. |
|---|---|
| Authors: | Lu, Ying1,2 (AUTHOR), Jiang, Xia1,2,3 (AUTHOR), Li, Youhong1,2,3 (AUTHOR), Li, Fenglin1,2 (AUTHOR), Zhao, Mengting3 (AUTHOR), Lin, Ye3 (AUTHOR), Jin, Lili1,2,3 (AUTHOR), Zhuang, Haihui1,2 (AUTHOR), Li, Shuangyue1,2 (AUTHOR), Ye, Peipei1,2 (AUTHOR), Pei, Renzhi1,2 (AUTHOR), Jin, Jie4 (AUTHOR), Jiang, Lei1,3 (AUTHOR) jianglei@nbu.edu.cn |
| Source: | Journal of Translational Medicine. 9/27/2024, Vol. 22 Issue 1, p1-18. 18p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
